Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults

Experimental Gerontology

Volumn 44, Issue 5, 2009, Pages 350-355

  Walston, Jeremy D ^a   Matteini, Amy M ^a   Nievergelt, Caroline ^b   Lange, Leslie A ^c   Fallin, Dani M ^a   Barzilai, Nir ^e   Ziv, Elad ^f   Pawlikowska, Ludmila ^f   Kwok, Pui ^f   Cummings, Steve R ^f   Kooperberg, Charles ^g   LaCroix, Andrea ^g   Tracy, Russell P ^d   Atzmon, Gil ^e   Lange, Ethan M ^c   Reiner, Alex P ^h  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Genetic epidemiology; IL 6; Inflammation; Longevity; PARP1

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; AGING; ALLELE; ARTICLE; FEMALE; GENETIC SCREENING; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGEVITY; MALE; PHENOTYPE; POLY(ADP-RIBOSE) POLYMERASES; RISK FACTORS;

EID: 64449084857     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.02.004     Document Type: Article

References (54)

1. Atzmon G., Pollin T.I., Crandall J., Tanner K., Schechter C.B., Scherer P.E., Rincon M., Siegel G., Katz M., Lipton R.B., Shuldiner A.R., and Barzilai N. Adiponectin levels and genotype: a potential regulator of life span in humans. J. Gerontol. A Biol. Sci. Med. Sci. 63 5 (2008) 447-453
2. Atzmon G., Rincon M., Schechter C.B., Shuldiner A.R., Lipton R.B., Bergman A., and Barzilai N. Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol. 4 4 (2006) e113
3. Barzilai N., Atzmon G., Schechter C., Schaefer E.J., Cupples A.L., Lipton R., Cheng S., and Shuldiner A.R. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290 15 (2003) 2030-2040
4. Beneke S., and Bürkle A. Poly(ADP-ribosyl)ation in mammalian ageing. Nucleic Acids Res. 35 22 (2007) 7456-7465
5. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74 (2004) 106-120
6. Cohen H.J., Harris T., and Pieper C.F. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med. 114 3 (2003) 180-187
7. Corander J., and Tang J. Bayesian analysis of population structure based on linked molecular information. Math. Biosci. 205 (2007) 19-31
8. Csiszar A., Wang M., Lakatta E.G., and Ungvari Z.I. Inflammation and endothelial dysfunction during aging: role of NF-{kappa}B. J. Appl. Physiol. 105 4 (2008) 1333-1341
9. Cummings S.R., Nevitt M.C., Browner W.S., Stone K., Fox K.M., Ensrud K.E., Cauley J., Black D., and Vogt T.M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N. Engl. J. Med. 332 12 (1995) 767-773
10. Cushman M., Cornell E.S., Howard P.R., Bovill E.G., and Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin. Chem. 41 (1995) 264-270
11. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., Wensley F., Higgins J.P., Lennon L., Eiriksdottir G., Rumley A., Whincup P.H., Lowe G.D., and Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 5 4 (2008) e78
12. de Craen A.J., Posthuma D., Remarque E.J., van den Biggelaar A.H., Westendorp R.G., and Boomsma D.I. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 6 2 (2005) 167-170
13. de la Lastra C.A., Villegas I., and Sánchez-Fidalgo S. Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications. Curr. Pharm. Des. 13 9 (2007) 933-962
14. de Maat M.P., Bladbjerg E.M., Hjelmborg J.B., Bathum L., Jespersen J., and Christensen K. Genetic influence on inflammation variables in the elderly. Arterioscler. Thromb. Vasc. Biol. 24 11 (2004) 2168-2173
15. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
16. Di Bona D., Vasto S., Capurso C., Christiansen L., Deiana L., Franceschi C., Hurme M., Mocchegiani E., Rea M., Lio D., Candore G., and Caruso C. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res. Rev. 8 1 (2009) 36-42
17. Dupuis J., Larson M.G., Vasan R.S., Massaro J.M., Wilson P.W., Lipinska I., Corey D., Vita J.A., Keaney Jr. J.F., and Benjamin E.J. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 182 2 (2005) 307-314
18. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51 (2000) 245-270
19. Ferrucci L., Harris T.B., Guralnik J.M., Tracy R.P., Corti M.C., Cohen H.J., Penninx B., Pahor M., Wallace R., and Havlik R.J. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47 6 (1999) 639-646
20. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., and Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 1 (2007) 92-105
21. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., Kuller L.H., Manolio T.A., Mittelmark M.B., Newman A., O'Leary D.H., Psaty B.M., Rautaharju P., Tracy R.P., and Weiler P.G. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1 (1991) 263-276
22. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8 Suppl. 2 (2006) S3
23. Galicia J.C., Tai H., Komatsu Y., Shimada Y., Akazawa K., and Yoshie H. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun. 5 6 (2004) 513-516
24. Grube K., and Bürkle A. Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc. Natl. Acad. Sci. USA 89 24 (1992) 11759-11763
25. Harris T.B., Ferrucci L., Tracy R.P., Corti M.C., Wacholder S., Ettinger Jr. W.H., Heimovitz H., Cohen H.J., and Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106 5 (1999) 506-512
26. Heikkilä K., Ebrahim S., Rumley A., Lowe G., and Lawlor D.A. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol. Biomarkers Prev. 16 6 (2007) 1155-1159
27. Hindorff L.A., Rice K.M., Lange L.A., Diehr P., Halder I., Walston J., Kwok P., Ziv E., Nievergelt C., Cummings S.R., Newman A.B., Tracy R.P., Psaty B.M., and Reiner A.P. Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis 197 2 (2008) 922-930
28. Huber S.A., Sakkinen P., Conze D., Hardin N., and Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2364-2367
29. Ives D.G., Fitzpatrick A.L., Bild D.E., Psaty B.M., Kuller L.H., Crowley P.M., Cruise R.G., and Theroux S. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann. Epidemiol. 5 (1995) 278-285
30. Jenny N.S., Tracy R.P., Ogg M.S., Luong le A., Kuller L.H., Arnold A.M., Sharrett A.R., and Humphries S.E. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 2066-2071
31. Jones S.A., Horiuchi S., Topley N., Yamamoto N., and Fuller G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15 1 (2001) 43-58
32. Knüpfer H., and Preiss R. sIL-6R: more than an agonist?. Immunol. Cell Biol. 86 1 (2008) 87-91
33. Lockett K.L., Hall M.C., Xu J., Zheng S.L., Berwick M., Chuang S.C., Clark P.E., Cramer S.D., Lohman K., and Hu J.J. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 64 17 (2004) 6344-6348
34. Muiras M.L., Müller M., Schächter F., and Bürkle A. Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians. J. Mol. Med. 76 5 (1998) 346-354
35. Nievergelt C.M., Libiger O., and Schork N.J. Generalized analysis of molecular variance. PLOS Genet. 3 4 (2007) e51
36. Penninx B.W., Kritchevsky S.B., Newman A.B., Nicklas B.J., Simonsick E.M., Rubin S., Nevitt M., Visser M., Harris T., and Pahor M. Inflammatory markers and incident mobility limitation in the elderly. J. Am. Geriatr. Soc. 52 7 (2004) 1105-1113
37. Qi L., Rifai N., and Hu F.B. Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Diabetes 56 12 (2007) 3075-3081
38. Rafiq S., Frayling T.M., Murray A., Hurst A., Stevens K., Weedon M.N., Henley W., Ferrucci L., Bandinelli S., Corsi A.M., Guralnik J.M., and Melzer D. A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects. Genes Immun. 8 7 (2007) 552-559
39. Reich D., Patterson N., Ramesh V., De Jager P.L., McDonald G.J., Tandon A., Choy E., Hu D., Tamraz B., Pawlikowska L., Wassel-Fyr C., Huntsman S., Waliszewska A., Rossin E., Li R., Garcia M., Reiner A., Ferrell R., Cummings S., Kwok P.Y., Harris T., Zmuda J.M., and Ziv E. Health, Aging and Body Composition (Health ABC) Study. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am. J. Hum. Genet. 80 4 (2007) 716-726
40. Reiner A.P., Ziv E., Lind D.L., Nievergelt C.M., Schork N.J., Cummings S.R., Phong A., Gonzalez B., Harris T.B., Psaty B.M., and Kwok P.-Y. Population structure, admixture, and aging-related phenotypes in African American adults: the Cardiovascular Health Study. Am. J. Hum. Genet. 76 (2005) 463-477
41. Reiner A.P., Barber M.J., Guan Y., Ridker P.M., Lange L.A., Chasman D.I., Walston J.D., Cooper G.M., Jenny N.S., Rieder M.J., Durda J.P., Smith J.D., Novembre J., Tracy R.P., Rotter J.I., Stephens M., Nickerson D.A., and Krauss R.M. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am. J. Hum. Genet. 82 5 (2008) 1193-1201
42. Reuben D.B., Cheh A.I., Harris T.B., Ferrucci L., Rowe J.W., Tracy R.P., and Seeman T.E. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning ommunity-dwelling older persons. J. Am. Geriatr. Soc. 50 4 (2002) 638-644
43. Ridker P.M., Pare G., Parker A., Zee R.Y., Danik J.S., Buring J.E., Kwiatkowski D., Cook N.R., Miletich J.P., and Chasman D.I. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am. J. Hum. Genet. 82 5 (2008) 1185-1192
44. Roubenoff R., Parise H., Payette H.A., Abad L.W., D'Agostino R., Jacques P.F., Wilson P.W., Dinarello C.A., and Harris T.B. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am. J. Med. 115 6 (2003) 429-435
45. Storey J.D., and Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100 (2003) 9440-9445
46. Störk S., Feelders R.A., van den Beld A.W., Steyerberg E.W., Savelkoul H.F., Lamberts S.W., Grobbee D.E., and Bots M.L. Prediction of mortality risk in the elderly. Am. J. Med. 119 6 (2006) 519-525
47. Su S., Snieder H., Miller A.H., Ritchie J., Bremner J.D., Goldberg J., Dai J., Jones L., Murrah N.V., Zhao J., and Vaccarino V. Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis 200 1 (2008) 213-220
48. Suh Y., Atzmon G., Cho M.O., Hwang D., Liu B., Leahy D.J., Barzilai N., and Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. USA 105 9 (2008) 3438-3442
49. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., and Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 128 1 (2007) 83-91
50. vB Hjelmborg J., Iachine I., Skytthe A., Vaupel J.W., McGue M., Koskenvuo M., Kaprio J., Pedersen N.L., and Christensen K. Genetic influence on human lifespan and longevity. Hum. Genet. 119 3 (2006) 312-321
51. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., and Harris T.B. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 7 (2001) 947-953
52. Walston J.D., Fallin M.D., Cushman M., Lange L., Psaty B., Jenny N., Browner W., Tracy R., Durda P., and Reiner A. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum. Genet. 122 5 (2007) 485-494
53. Wang X.G., Wang Z.Q., Tong W.M., and Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem. Biophys. Res. Commun. 354 1 (2007) 122-126
54. Wörns M.A., Victor A., Galle P.R., and Höhler T. Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels - a study in twins. Genes Immun. 7 7 (2006) 600-605